VAERS Explorer
Back to explore

Report #2871467

Received Nov 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
IN
Recovered
Unknown
Vaccinated
Oct 24, 2025
Onset
Oct 28, 2025
Days to onset
4
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATIONUNK——

Symptoms (1)

Hepatitis B virus test positive

Symptom narrative

Received HEPLISAV-B, Positive Test Result for Hepatitis B; Initial report received on 04-Nov-2025. A pharmacist reported that a female patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization then showed a positive test result for hepatitis B virus. No medical history or concomitant medications were reported. On 24-Oct-2025, the patient received an unknown dose of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 28-Oct-2025, four days after receiving HEPLISAV-B, the patient attempted to donate blood but was denied donation because she showed a positive test result for hepatitis B virus. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.